These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 45452

  • 21. [Neuroleptic parkinsonism and tardive dyskinesia and methods of pharmacologically correcting these pathologic conditions (review)].
    Arushanian EB.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):269-77. PubMed ID: 2858951
    [No Abstract] [Full Text] [Related]

  • 22. The neuroleptics. 2. Neurophysiology and neuropharmacology.
    Albe-Fessard D, Bradley PB, Gerschenfeld HM, Herz A, Krnjević K, Lodin Z, Marczynski TJ, Massion J, Meulders M, Poirier LJ, Salmoiraghi GC, Schlag J, Tauc L, Wall PD.
    Mod Probl Pharmacopsychiatry; 1970; 5():12-22. PubMed ID: 4348144
    [No Abstract] [Full Text] [Related]

  • 23. Dopaminergic and cholinergic mechanisms in relation to postural tremor in the monkey and circling movements in the cat.
    Poirier LJ, Langelier P, Bédard P, Boucher R, Larochelle L, Parent A, Roberge AG.
    Adv Neurol; 1974; 5():5-10. PubMed ID: 4216259
    [No Abstract] [Full Text] [Related]

  • 24. The susceptibility to acetylcholine and dopamine in the caudate nucleus of cats with chronic nigrostriatal lesions.
    Sphelmann R.
    Trans Am Neurol Assoc; 1974; 99():255-7. PubMed ID: 4156892
    [No Abstract] [Full Text] [Related]

  • 25. Evidence for NMDA/D2 receptor-receptor interactions in the rat striatum.
    Micheletti G, Lannes B, Warter JM, Zwiller J.
    Adv Neurol; 1993; 60():128-32. PubMed ID: 8380517
    [No Abstract] [Full Text] [Related]

  • 26. Is the striato-nigral pathway responsible for 'feed-back' control of dopamine release [proceedings]?
    Arbuthnott GW, Garcia-Munoz M, Nicolaou NM, Tulloch IF, Wright AK.
    Br J Pharmacol; 1976 Oct; 58(2):272P. PubMed ID: 974393
    [No Abstract] [Full Text] [Related]

  • 27. Noradrenaline loss selectivity exacerbates nigrostriatal toxicity in different species of rodents.
    Fornai F, Bassi L, Bonaccorsi I, Giorgi F, Corsini GU.
    Funct Neurol; 1997 Oct; 12(3-4):193-8. PubMed ID: 9218976
    [No Abstract] [Full Text] [Related]

  • 28. Dopaminergic involvement in hypothalamic function: extrahypothalamic and hypothalamic control. A neuroanatomical analysis.
    Fuxe K, Goldstein M, Hökfelt T, Jonsson G, Lidbrink P.
    Adv Neurol; 1974 Oct; 5():405-19. PubMed ID: 4374065
    [No Abstract] [Full Text] [Related]

  • 29. Cellular interactions in the striatum involving neuronal systems using "classical" neurotransmitters: possible functional implications.
    Nieoullon A, Kerkerian-Le Goff L.
    Mov Disord; 1992 Oct; 7(4):311-25. PubMed ID: 1362449
    [Abstract] [Full Text] [Related]

  • 30. Non-adrenergic, non-cholinergic autonomic neurotransmission mechanisms.
    Burnstock G, Hökfelt T, Gershon MD, Iversen LL, Kosterlitz HW, Szurszewski JH.
    Neurosci Res Program Bull; 1979 Jun; 17(3):377-519. PubMed ID: 42027
    [No Abstract] [Full Text] [Related]

  • 31. An electrophysiological study on pathways of the cortico-striato-pallido-center median systems in the cat.
    Blum B, Elizur A, Wijsenbeek H.
    Int J Neurol; 1975 Jun; 9(3-4):287-97. PubMed ID: 1225855
    [No Abstract] [Full Text] [Related]

  • 32. Blockade by frontocortical lesion of reciprocal regulation between the two nigrostriatal dopaminergic pathways.
    Leviel V, Kerny C, Barberis C, Guibert B, Daudet F.
    Neuroscience; 1984 Sep; 13(1):53-9. PubMed ID: 6092996
    [Abstract] [Full Text] [Related]

  • 33. Regulations of the activity of the nigrostriatal dopaminergic pathways by cortical, cerebellar, and sensory neuronal afferences.
    Glowinski J, Niecoullon A, Chéramy A.
    Adv Biochem Psychopharmacol; 1978 Sep; 19():75-87. PubMed ID: 358788
    [No Abstract] [Full Text] [Related]

  • 34. [Functional organization of monosynaptic interneuronal connections in the cerebral cortex].
    Sil'kis IG.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1978 Sep; 28(3):643-9. PubMed ID: 209640
    [Abstract] [Full Text] [Related]

  • 35. Lesions of the striatopetal dopamine and serotonin pathways: anatomy and chemistry.
    Poirier LJ, Sourkes TL.
    Pharmacol Ther B; 1976 Sep; 2(1):19-27. PubMed ID: 817331
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Liberation of labelled L-glutamic acid from rat neostriatum upon stimulation of the frontal cortex during in vivo experiments].
    Godukhin OV, Zharikova AD, Novoselov VI.
    Fiziol Zh SSSR Im I M Sechenova; 1979 Oct; 65(10):1544-8. PubMed ID: 41746
    [No Abstract] [Full Text] [Related]

  • 38. Dissociable properties of dopamine neurons im the nigrostriatal and mesolimbic dopamine systems.
    Koob GF, Del Fiacco M, Iversen SD.
    Adv Biochem Psychopharmacol; 1977 Oct; 16():589-95. PubMed ID: 560793
    [No Abstract] [Full Text] [Related]

  • 39. Functional aspects of serotonin transmission in the basal ganglia: a review and an in vivo approach using the push-pull cannula technique.
    Soubrié P, Reisine TD, Glowinski J.
    Neuroscience; 1984 Nov; 13(3):605-25. PubMed ID: 6084828
    [No Abstract] [Full Text] [Related]

  • 40. Functional interaction between rat substantia nigra and striatum: GABA and dopamine interrelation.
    Racagni G, Bruno F, Cattabeni F, Maggi A, Di Giulio AM, Parenti M, Groppetti A.
    Brain Res; 1977 Oct 07; 134(2):353-8. PubMed ID: 890495
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.